Illumina

Youtube Subscribe

Open: 195.96 Close: 196.54 Change: 0.58

Stop waiting time to find out about Illumina Company Inc: Our AI summarizes all info about it.

Are looking for the most relevant information about Illumina? Investor spend a lot of time searching for information to make investment decisions in Illumina. This task is often burdensome and consumes huge amounts of free time. It also leads to mistakes due to fatigue and bounded rationality. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Illumina are: Illumina, Icahn, vulnerability, Illuminas, Carl, revenue, result, and the most common words in the summary are: illumina, sequence, news, stock, product, market, illuminas, . One of the sentences in the summary was: Icahn is engaged in a proxy contest with the DNA sequencing firm. Other searches …

Concept Map

Semantic Network

Stock Summary

Illumina, Inc. develops, manufactures, and markets life science tools and integrated systems for large-scale analysis of genetic variation and function. The company offers sequencing and array-based instruments and consumables, which include reagents, flow.

Today's Summary

Carl Icahn calls Illumina Q1 results ‘very disappointing, slams cost-cutting plan. Icahn is engaged in a proxy contest with the DNA sequencing firm. The vulnerabilities affect Illuminas iScan, iSeq, MiniSeq and MiSeq products.

Today's News

Illumina CEO Francis deSouza said in January that its installed base was more than 22,000 sequencers. The vulnerabilities affect Illuminas iScan, iSeq, MiniSeq and MiSeq products. Illumina CTO Alex Aravanis said the company discovered the vulnerability as part of routine. Illumina reported a negative operating margin of 5.7% for the quarter, down from 15% during the same period a year ago. Illumina did not immediately respond to a request for comment on Icahns letter. Illumina delivered revenue of approximately $1.09 billion and diluted non-GAAP EPS of $0.08 in Q1. Core Illumina revenue of $1.08 billion was down 12% year-over-year, net of the effects of hedging. Sequencing consumables revenue was up 1% sequentially, but down 12%, as expected. Illumina Inc. announced outcomes from its annual The Future Is Bright campaign. Illumina has reached more than 1.2 million learners in 11 countries worldwide since 2019. The company will reduce its annualized run rate expenses by more than $100 million. Illumina aims to reach 5 million STEM learners by 2030 globally. Icahn is engaged in a proxy contest with the DNA sequencing firm. “Icahn has launched a self-serving and deliberately misleading campaign against our company, Illumina said. Illumina has developed a software patch to protect against the cybersecurity vulnerability being exploited. The possible impact on genomic data includes causing instruments to provide no results, incorrect results, or altered results. Illumina committed to achieving Core Illumina non-GAAP operating margins of 25% in 2024 and 27% in 2025[2] Reiterated consolidated revenue guidance of 7% to 10% growth from 2022. Illumina does not endorse Carl Icahn or his unqualified nominees and believes the election of any such nominees would detract from Illuminas strong momentum. Icahn has repeatedly noted that he has not developed an investment thesis, does not know how to run the business. Illumina products from Illumina that are vulnerable include: (iScanq, iSeq, MiniSeq,. MiSeq). According to David McAlpine, an Illumina spokesperson, has not received any reports that any vulnerabilities have been used. Illumina Universal Copy Service (UCS) from Illumina has two vulnerabilities. The vulnerabilities exist in the Illumina universal Copy Service software, allowing remote code execution attacks. The FDA directed Illumina to notify impacted customers on April 5, 2023. Illumina reported installing 67 NovaSeq X systems in the first quarter. Reiterating earlier guidance, Illumina continues to forecast 7–10% revenue growth. Icahn has stepped up his war of words against Illumina in recent days. Icahn is nominating three allies to Illuminas board. Illumina has rejected the three as lacking the qualifications and experience it seeks. The affected products include Illuminas iScan, iSeq, MiniSeq and MiSeq. The vulnerability could allow attackers to take remote control of devices. No reports have been received of this vulnerability having been exploited. Illumina has on average historically risen by 39.6% based on the past 22 years of stock performance. The current Illumina [ ILMN ] share price is $195.16 USD today. Illumina, Inc. (ILMN) stock price, quote & news - stock analysis. Click here - the ILMN analysis is free. Illumina (ILMN) came out with quarterly earnings of $0.08 per share, beating the Zacks Consensus Estimate of $ 0.02 per share. The plans aim to reduce Illuminas annualized run rate expenses by more than $100 million. Carl C. Icahn released the following open letter to the shareholders of Illumina, Inc. Carl Icahn. Icahn to Commence Investigation into Value Destruction. Carl Icahn calls Illumina Q1 results ‘very disappointing, slams cost-cutting plan. Carl Icahahn on Friday called Illuminas first-quarter results very disappointing and sl... Carl Ichan on Friday: Very disappointing

Stock Profile

"Illumina, Inc. develops, manufactures, and markets life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through Core Illumina and GRAIL segments. The company offers sequencing and array-based instruments and consumables, which include reagents, flow cells, and library preparation; and whole-genome sequencing kits, which sequence entire genomes of any size and complexity, and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. Further, it provides whole-genome sequencing, genotyping, NIPT, and product support services; and Galleri, a multi-cancer early detection test. The company serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. Further, it markets and distributes its products directly to customers in North America, Europe, Latin America, and the Asia-Pacific region, as well as sells through life-science distributors in various markets within Europe, the Asia-Pacific region, Latin America, the Middle East, and Africa. Illumina, Inc. was incorporated in 1998 and is headquartered in San Diego, California."

Keywords

The game is changing. There is a new strategy to evaluate Illumina fundamental value, possible risks and most salient advantages. Investors have traditionally relied in reading large amounts of text to evaluate the fundamental value of a stock or company. However, the development of Artificial Intelligence (AI) tools is modifying the way investments are evaluated in markets. Today, machine learning, natural language processing and bigdata allow making this process automatic, reducing large amounts of text to the elements that have a higher activation in a neural network. We programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Illumina are: Illumina, Icahn, vulnerability, Illuminas, Carl, revenue, result, and the most common words in the summary are: illumina, sequence, news, stock, product, market, illuminas, . One of the sentences in the summary was: Icahn is engaged in a proxy contest with the DNA sequencing firm. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #illumina #sequence #news #stock #product #market #illuminas.

Read more →

Youtube Subscribe

---